SureNano Science Ltd. (SURE.CN)
CAD 0.04
(0.0%)
CAD 0.04
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | - | - | 18 Thousand | 36 Thousand |
| Cost of Revenue | 2500.00 | 3750.00 | 1487.00 | 1342.00 |
| Gross Profit | -2500.00 | -3750.00 | 16.51 Thousand | 34.65 Thousand |
| Operating Expenses | 277.38 Thousand | 385.67 Thousand | 1.13 Million | 116.24 Thousand |
| Selling, General and Administrative Expenses | 268.71 Thousand | 346.73 Thousand | 1.03 Million | 116.24 Thousand |
| Research and Development Expenses | 8674.00 | 38.94 Thousand | 102.36 Thousand | - |
| Other Expenses | - | - | - | - |
| Cost and Expenses | 279.88 Thousand | 389.42 Thousand | 1.13 Million | 117.58 Thousand |
| Operating Income | -279.88 Thousand | -389.43 Thousand | -1.11 Million | -81.59 Thousand |
| Interest Expense | - | - | - | - |
| Income Tax Expense | -279.88 Thousand | - | 915.00 | 925.00 |
| Earnings before Tax | -279.88 Thousand | -384.01 Thousand | -1.11 Million | -81.58 Thousand |
| Net Income | -279.88 Thousand | -384.01 Thousand | -1.11 Million | -82.51 Thousand |
| Earnings Per Share Basic | -0.01 | -0.02 | -0.05 | -0.00 |
| Earnings Per Share Diluted | -0.01 | -0.02 | -0.05 | -0.00 |
| Weighted Average Shares Outstanding | 21.45 Million | 21.45 Million | 21.45 Million | 19.7 Million |
| Weighted Average Shares Outstanding (Diluted) | 21.45 Million | 21.45 Million | 21.45 Million | 19.7 Million |
| Gross Margin | - | - | 0.92 | 0.96 |
| EBIT Margin | - | - | -62.10 | -2.27 |
| Profit Margin | - | - | -62.15 | -2.29 |
| EBITDA | -277.38 Thousand | -380.26 Thousand | -1.11 Million | -81.58 Thousand |
| Earnings Before Tax Margin | - | - | -62.10 | -2.27 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 625.00 | 625.00 | 2500.00 | 625.00 | 625.00 | 625.00 |
| Gross Profit | -625.00 | -625.00 | -2500.00 | -625.00 | -625.00 | -625.00 |
| Operating Expenses | 57.85 Thousand | 81.5 Thousand | 277.38 Thousand | 64.93 Thousand | 62.66 Thousand | 79.85 Thousand |
| Selling, General and Administrative Expenses | 57.85 Thousand | 81.5 Thousand | - | 64.74 Thousand | 61.43 Thousand | 54.63 Thousand |
| Research and Development Expenses | - | - | - | 197.00 | 1230.00 | 7247.00 |
| Other Expenses | - | 38.09 Thousand | - | - | - | - |
| Cost and Expenses | 58.47 Thousand | 82.12 Thousand | 279.88 Thousand | 65.56 Thousand | 63.29 Thousand | 79.85 Thousand |
| Operating Income | -58.47 Thousand | -82.13 Thousand | -279.89 Thousand | -65.56 Thousand | -63.29 Thousand | -79.85 Thousand |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -625.00 | 5.00 | - | 5.00 | 6.00 | 1.00 |
| Earnings before Tax | -58.47 Thousand | -82.12 Thousand | -279.88 Thousand | -65.56 Thousand | -63.29 Thousand | -79.85 Thousand |
| Net Income | -58.47 Thousand | -82.12 Thousand | -279.88 Thousand | -65.56 Thousand | -63.29 Thousand | -79.85 Thousand |
| Earnings Per Share Basic | -0.00 | -0.00 | - | -0.00 | -0.00 | -0.00 |
| Earnings Per Share Diluted | -0.00 | -0.00 | - | -0.00 | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | 21.45 Million | 21.45 Million | 21.45 Million | 21.45 Million | 21.45 Million | 21.45 Million |
| Weighted Average Shares Outstanding (Diluted) | 21.45 Million | 21.45 Million | 21.45 Million | 21.45 Million | 21.45 Million | 21.45 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -58.47 Thousand | -81.5 Thousand | - | -64.93 Thousand | -62.65 Thousand | -79.23 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
PGIL
SPAL
EEGI
AKRRF
688087
360